We are live on
!
Find out more
Arax Advisory Partners Portfolio holdings
AUM
$15.1B
Turnover
30.22%
1-Year Est. Return
27.93%
This Fund
S&P 500
This Quarter
Est. Return
+16%
1 Year Est. Return
+27.93%
3 Year Est. Return
+64.69%
5 Year Est. Return
+64.07%
10 Year Est. Return
–
AUM
$15.1B
AUM Growth
+$11.5B
(+326%)
Cap. Flow
+$10.9B
Cap. Flow
% of AUM
71.99%
Top 10 Holdings %
Top 10 Hldgs %
18.25%
Holding
5,282
New
1,518
Increased
3,295
Reduced
222
Closed
78
Avg Time Held Equity + Options
1.4
years
Top 10 Avg Time Held Equity + Options
0.6
years
Top 20 Avg Time Held Equity + Options
0.8
years
Avg Time Held Equity only
1.4
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$331M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$324M |
| 3 |
NVIDIA
NVDA
|
+$260M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$219M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares High Yield Muni Active ETF
HIMU
|
+$4.53M |
| 2 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$3.23M |
| 3 |
Dimensional Emerging Markets Core Equity 2 ETF
DFEM
|
+$2.25M |
| 4 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$2.21M |
| 5 |
Capital Group Growth ETF
CGGR
|
+$1.45M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.68% |
| 2 | Technology | 13.1% |
| 3 | Industrials | 6.81% |
| 4 | Financials | 6.59% |
| 5 | Energy | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
DMRA
5126
Damora Therapeutics
DMRA
$1.16B
| $130 | ﹤0.01% |
+5
| New | +$121 |
2026 Q2
0 quarters
|
|
5127
DELISTED
Xoma
XOMA
| $128 | ﹤0.01% |
+3
| New | +$122 |
2026 Q2
0 quarters
|
|
5128
Opendoor Technologies Inc Series A Warrants
OPENL
$2.2M
| $126 | ﹤0.01% |
444
+385
| +653% | +$118 |
2025 Q4
2 quarters
|
|
5129
Rareview Systematic Equity ETF
RSEE
$80.1M
| $119 | ﹤0.01% |
+3
| New | +$113 |
2026 Q2
0 quarters
|
|
5130
Paradium.AI, Inc.
PAAI
$41.9M
| $113 | ﹤0.01% |
+136
| New | +$236 |
2026 Q2
0 quarters
|
|
5131
Inovio Pharmaceuticals
INO
$104M
| $113 | ﹤0.01% |
+103
| New | +$122 |
2026 Q2
0 quarters
|
|
5132
AdvisorShares Pure Cannabis ETF
YOLO
$29.9M
| $110 | ﹤0.01% |
38
+31
| +443% | +$92 |
2022 Q4
14 quarters
|
|
5133
Mobix Labs
MOBX
$13.6M
| $109 | ﹤0.01% |
+52
| New | +$125 |
2026 Q2
0 quarters
|
|
5134
DELISTED
Esperion Therapeutics
ESPR
| $107 | ﹤0.01% |
+34
| New | +$95 |
2026 Q2
0 quarters
|
|
|
5135
Opendoor Technologies Inc Series Z Warrants
OPENZ
$2.06M
| $107 | ﹤0.01% |
444
+440
| +11,000% | +$126 |
2025 Q4
2 quarters
|
|
5136
Telecom Argentina
TEO
$5.41B
| $104 | ﹤0.01% |
+8
| New | +$101 |
2026 Q2
0 quarters
|
|
5137
Peraso
PRSO
$5.59M
| $101 | ﹤0.01% |
+111
| New | +$109 |
2026 Q2
0 quarters
|
|
5138
Rareview Total Return Bond ETF
RTRE
$61.3M
| $100 | ﹤0.01% |
+4
| New | +$100 |
2026 Q2
0 quarters
|
|
5139
Lexicon Pharmaceuticals
LXRX
$685M
| $98 | ﹤0.01% |
41
| – | – |
2025 Q3
3 quarters
|
|
5140
Kyverna Therapeutics
KYTX
$354M
| $98 | ﹤0.01% |
11
| – | – |
2025 Q3
3 quarters
|
|
5141
Commercial Vehicle Group
CVGI
$116M
| $93 | ﹤0.01% |
+20
| New | +$94 |
2026 Q2
0 quarters
|
|
5142
Blink Charging
BLNK
$62.6M
| $92 | ﹤0.01% |
143
+38
| +36% | +$28 |
2022 Q4
14 quarters
|
|
5143
C4 Therapeutics
CCCC
$338M
| $89 | ﹤0.01% |
19
-300
| -94% | -$1.03K |
2025 Q3
3 quarters
|
|
5144
Aeluma Inc
ALMU
$161M
| $88 | ﹤0.01% |
+4
| New | +$86 |
2026 Q2
0 quarters
|
|
|
HELP
5145
Helus Pharma Inc. Common Stock
HELP
$780M
| $86 | ﹤0.01% |
+13
| New | +$65 |
2026 Q2
0 quarters
|
|
5146
Astoria US Quality Kings ETF
ROE
$288M
| $85 | ﹤0.01% |
+2
| New | +$80 |
2026 Q2
0 quarters
|
|
5147
Talphera
TLPH
$56.1M
| $83 | ﹤0.01% |
81
| – | – |
2025 Q4
2 quarters
|
|
5148
KORU Medical Systems
KRMD
$138M
| $79 | ﹤0.01% |
+19
| New | +$78 |
2026 Q2
0 quarters
|
|
5149
Power Solutions International
PSIX
$1.09B
| $78 | ﹤0.01% |
+2
| New | +$110 |
2026 Q2
0 quarters
|
|
5150
Acumen Pharmaceuticals
ABOS
$122M
| $69 | ﹤0.01% |
26
| – | – |
2025 Q3
3 quarters
|
|
Similar funds
Arax Advisory Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Arax Advisory Partners held 5,282 positions worth $15.1B, up 326% from $3.54B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arax Advisory Partners deployed $10.9B of net new capital in Q2 2026, opening 1,518 new positions and adding to 3,295 existing holdings. Its largest new stake was ClearShares Piton Intermediate Fixed Income ETF: 984,286 shares worth $92M.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 70% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was iShares High Yield Muni Active ETF, an estimated $4.53M trimmed.
- Arax Advisory Partners's largest Q2 2026 buy was ClearShares Piton Intermediate Fixed Income ETF: 984,286 shares worth $92M.
- Arax Advisory Partners added most to Apple in Q2 2026, an estimated $331M increase.
- Arax Advisory Partners's biggest Q2 2026 reduction was iShares High Yield Muni Active ETF, cutting an estimated $4.53M.
- Arax Advisory Partners fully exited Monroe Capital Corp in Q2 2026, selling an estimated $379K.
- Arax Advisory Partners's ten largest holdings make up 18% of its $15.1B portfolio in Q2 2026.
- Arax Advisory Partners opened 1,518 new positions and closed 78 in Q2 2026.
- Arax Advisory Partners's portfolio value rose 326% quarter-over-quarter to $15.1B.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.